Different Local Anesthetic Volumes for Unilateral Spinal Anesthesia

June 3, 2025 updated by: Atakan Sezgi, Ankara Etlik City Hospital

Different Local Anesthetic Volumes for Unilateral Spinal Anesthesia in Varicose Vein Surgery

Varicose veins are irreversible and abnormal enlargement of the veins. These veins appear and there are curled swellings under the skin in the feet and legs. Complaints increase when standing and sitting for long periods. For varicose veins in the initial stages, medical treatment methods such as compression socks (elastic socks) and elevating the feet as much as possible can be tried. For widespread varicose veins in more advanced stages, invasive procedures such as sclerotherapy and endovascular ablation are performed. These procedures can be performed under local, spinal or general anesthesia.

Spinal anesthesia; It is a type of neuraxial type of regional anesthesia characterized by injecting local anesthetic drugs into the subarachnoid space alone or together with other drugs, resulting in temporary sensory block, motor block, and sympathetic block. The local anesthetic volume administered during spinal anesthesia may affect the anesthesia levels and discharge times of the patients. For varicose vein surgeries, low-dose local anesthetic is sufficient for spinal anesthesia and can also provide early discharge.

This study will compare the peri-operative effects of different doses of spinal anesthesia in patients undergoing varicose vein surgery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ankara
      • Yenimahalle, Ankara, Turkey, 06170
        • Ankara Etlik City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged 18-80 years
  • American Society of Anesthesiologists (ASA) score I-II
  • Body Mass Index (BMI) between 18-30 kg/m2
  • Patients who underwent spinal anesthesia (bupivacaine 4 mg or 6 mg) for varicose vein surgery in the operating theatre

Exclusion Criteria:

  • Patients under 18 and over 80 years of age
  • ASA score III and above
  • Patients with a history of bleeding diathesis
  • Patients with infection in the area to be treated
  • BMI below 18 or above 30 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Spinal anesthesia with 4 mg bupivacaine
After the patients are monitored, they will be placed in the lateral decubitus position. After appropriate field sterilization, patients will undergo unilateral spinal anesthesia with 4 mg bupivacaine. At the fifth minute after spinal anesthesia, patients will be placed in the supine position.
Spinal anesthesia was applied to the patients with 4 mg bupivacaine in the lateral decubitus position.
Active Comparator: Spinal anesthesia with 6 mg bupivacaine
After the patients are monitored, they will be placed in the lateral decubitus position. After appropriate field sterilization, patients will undergo unilateral spinal anesthesia with 6 mg bupivacaine. At the fifth minute after spinal anesthesia, patients will be placed in the supine position.
Spinal anesthesia was applied to the patients with 6 mg bupivacaine in the lateral decubitus position.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Discharge time
Time Frame: On the operation day
The time (minutes) from the application of spinal anesthesia to the patients' discharge will be recorded as the discharge period.
On the operation day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor block appearing time
Time Frame: On the operation day
Time (minutes) to complete motor block in the lower extremity after spinal anesthesia
On the operation day
Sensorial block appearing time
Time Frame: On the operation day
Time (minutes) to complete sensorial block in the lower extremity after spinal anesthesia
On the operation day
Motor block disappearing time
Time Frame: On the operation day
Time (minutes) to disappearance of complete motor block in the lower extremity after spinal anesthesia
On the operation day
Sensorial block disappearing time
Time Frame: On the operation day
Time (minutes) to disappearance of sensorial block in the lower extremity after spinal anesthesia
On the operation day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2024

Primary Completion (Actual)

May 10, 2025

Study Completion (Actual)

May 30, 2025

Study Registration Dates

First Submitted

July 25, 2024

First Submitted That Met QC Criteria

July 25, 2024

First Posted (Actual)

July 30, 2024

Study Record Updates

Last Update Posted (Actual)

June 4, 2025

Last Update Submitted That Met QC Criteria

June 3, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Anesthesia

Clinical Trials on 4 mg bupivacaine

Subscribe